Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2016 May 28;11:74. doi: 10.1186/s13014-016-0652-4

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s). 2016

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

PMC Copyright notice

Fig. 1 — CyberKnife treatment plan of a 226 cc metastasis in the upper liver overlaid on contrast enhanced T1-weighted MRI in axial (upper right), sagittal (lower left), and coronal (lower right) view. The prescription dose to the planning target volume was lowered to 3 × 12 Gy (BED₁₀ = 79.2 Gy₁₀) to the 60 % isodose due to the size and critical organ constraints (i.e., the heart). The mean gross tumor volume dose was optimized to 140 Gy₁₀. Twenty-eight months after treatment, the patient was alive and had complete response with no further development of metastases in the meantime. Upper left: Planning CT with final CyberKnife treatment beams (cyan) from the initially generated beam assortment (blue/red)